Cargando…

A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)

BACKGROUND: Lung cancer is the leading cause of cancer deaths worldwide. Surgery, radiotherapy at conventional and high dose and chemotherapy are the mainstay for lung cancer treatment. Insufficient migration and activation of tumour specific effector T cells seem to be important reasons for inadequ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Safi, Seyer, Beckhove, Philipp, Warth, Arne, Benner, Axel, Roeder, Falk, Rieken, Stefan, Debus, Juergen, Dienemann, Hendrik, Hoffmann, Hans, Huber, Peter E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684916/ https://www.ncbi.nlm.nih.gov/pubmed/26686362 http://dx.doi.org/10.1186/s12885-015-2006-2

Ejemplares similares

Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy
por: Thieke, Christian, et al.
Publicado: (2015)

Development and Validation of a Risk Score for Predicting Death after Pneumonectomy
por: Safi, Seyer, et al.
Publicado: (2015)

Low-dose photon irradiation induces invasiveness through the SDF-1α/CXCR4 pathway in malignant mesothelioma cells
por: Yamauchi, Yoshikane, et al.
Publicado: (2017)

Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer
por: Timke, Carmen, et al.
Publicado: (2011)

Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer
por: Safi, Seyer, et al.
Publicado: (2019)

Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer
por: Safi, Seyer, et al.
Publicado: (2020)

A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer
por: Reissfelder, Christoph, et al.
Publicado: (2011)

Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial
por: Hauswald, Henrik, et al.
Publicado: (2015)

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
por: Zabeck, Heike, et al.
Publicado: (2018)

Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: A large scale study of 1465 non-small cell lung cancer cases
por: Kriegsmann, Mark, et al.
Publicado: (2015)

Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer
por: Roeder, Falk, et al.
Publicado: (2011)

B cell-regulated immune responses in tumor models and cancer patients
por: Fremd, Carlo, et al.
Publicado: (2013)

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series
por: Bernhardt, Denise, et al.
Publicado: (2018)

Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer – a retrospective single center analysis
por: Saleh-Ebrahimi, Ladan, et al.
Publicado: (2013)

Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma
por: Adeberg, Sebastian, et al.
Publicado: (2019)

Vaccine immune boost
por: Le Page, Michael
Publicado: (2020)

Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas
por: Rieber, Juliane, et al.
Publicado: (2015)

Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates
por: Marcus, Hadar, et al.
Publicado: (2021)

Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading
por: Jesinghaus, Moritz, et al.
Publicado: (2022)

Intraoperative Electron Radiation Therapy (IOERT) in the management of locally recurrent rectal cancer
por: Roeder, Falk, et al.
Publicado: (2012)

Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome
por: Jensen, Alexandra D, et al.
Publicado: (2015)

Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma
por: Schneider, Marc A., et al.
Publicado: (2016)

Boosting innate immunity in cancer
por: Van Epps, Heather L.
Publicado: (2005)

LOX-1 boosts immunity
por: Oh, SangKon, et al.
Publicado: (2015)

Therapy option for early-stage lung cancer in nonsurgical patients
por: Safi, Seyer, et al.
Publicado: (2022)

Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck
por: Akbaba, Sati, et al.
Publicado: (2019)

“Immune Boosting” in the time of COVID: selling immunity on Instagram
por: Wagner, Darren N., et al.
Publicado: (2020)

Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis
por: Roeder, Falk, et al.
Publicado: (2012)

Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer
por: Roeder, Falk, et al.
Publicado: (2014)

Intensity modulated radiotherapy (IMRT) in benign giant cell tumors -- a single institution case series and a short review of the literature
por: Roeder, Falk, et al.
Publicado: (2010)

Ginseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune System
por: Kang, Soowon, et al.
Publicado: (2012)

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Is boosting the immune system in sepsis appropriate?
por: Cavaillon, Jean-Marc, et al.
Publicado: (2014)

Boosting plant immunity with CRISPR/Cas
por: Chaparro-Garcia, Angela, et al.
Publicado: (2015)

Albumin Gains Immune Boosting Credibility
por: Gleeson, Michael W, et al.
Publicado: (2015)

Waning and boosting: on the dynamics of immune status
por: Diekmann, O., et al.
Publicado: (2018)

Boosting Immunity against Multiple Myeloma
por: Lopes, Raquel, et al.
Publicado: (2021)

Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022)

P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen
por: Casazza, JP, et al.
Publicado: (2009)

FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas
por: Milewski, David, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gkhmd51vajgte1ibp22fi3un1u